Antiserum agar method for identification of Smith type exopolysaccharides in clinical isolates of Staphylococcus aureus
- PMID: 3988894
- PMCID: PMC271702
- DOI: 10.1128/jcm.21.4.490-492.1985
Antiserum agar method for identification of Smith type exopolysaccharides in clinical isolates of Staphylococcus aureus
Abstract
We used an antiserum agar method to identify clinical Staphylococcus aureus strains producing an exopolysaccharide antigenically identical to the S. aureus Smith diffuse strain. S. aureus blood isolates were obtained from 137 patients, and three additional isolates were obtained from bone debridement. The 140 patients were clinically divided into the following groups: endocarditis (7 patients); pneumonia, empyema, or both (33 patients); intravascular device (34 patients); superficial or wound infection or both (35 patients); deep tissue infections (18 patients); and 6, unknown bacteremias (13 patients). Ninety (64.3%) of the total 140 S. aureus isolates were found to produce precipitin halos on the antiserum agar. The percentage was greatest in the isolates from the endocarditis group (100%) and least in deep tissue infections (55.5%). The presence of clinical S. aureus strains producing exopolysaccharides antigenically identical to the Smith diffuse strain exopolysaccharide appears to be a common phenomenon.
Similar articles
-
Detection of encapsulation in Staphylococcus aureus by use of antiserum agar.J Clin Microbiol. 1984 Aug;20(2):141-4. doi: 10.1128/jcm.20.2.141-144.1984. J Clin Microbiol. 1984. PMID: 6490810 Free PMC article.
-
Immunological characterization of an exopolysaccharide from the Staphylococcus aureus strain Smith diffuse.J Gen Microbiol. 1987 Feb;133(2):431-8. doi: 10.1099/00221287-133-2-431. J Gen Microbiol. 1987. PMID: 3655727
-
Staphylococcus aureus exopolysaccharide in vivo demonstrated by immunomagnetic separation and electron microscopy.J Clin Microbiol. 1989 Jul;27(7):1631-5. doi: 10.1128/jcm.27.7.1631-1635.1989. J Clin Microbiol. 1989. PMID: 2671021 Free PMC article.
-
Vaccine potential of poly-1-6 beta-D-N-succinylglucosamine, an immunoprotective surface polysaccharide of Staphylococcus aureus and Staphylococcus epidermidis.J Biotechnol. 2000 Sep 29;83(1-2):37-44. doi: 10.1016/s0168-1656(00)00296-0. J Biotechnol. 2000. PMID: 11000458 Review.
-
Potential for vaccination against infections caused by Staphylococcus aureus.Vaccine. 1991 Apr;9(4):221-7. doi: 10.1016/0264-410x(91)90103-d. Vaccine. 1991. PMID: 2058264 Review.
Cited by
-
Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis.J Exp Med. 2000 Jan 3;191(1):147-56. doi: 10.1084/jem.191.1.147. J Exp Med. 2000. PMID: 10620613 Free PMC article.
-
Staphylococcal peritonitis in patients on continuous peritoneal dialysis.J Clin Microbiol. 1986 May;23(5):809-12. doi: 10.1128/jcm.23.5.809-812.1986. J Clin Microbiol. 1986. PMID: 3711267 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources